Publications by authors named "Avner Thaler"

Claim this Profile
H
High Genetic Diagnostic Yield for Patients with Rare Movement Disorders at a Single-Center Neurogenetics Clinic.
Dvir Penn, Yam Amir, Gil Ben David, Alina Kurolap, Dalit Barel, Avner Thaler

Mov Disord Clin Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying motor-cognitive reserve using a novel multi-modal stress test.
Tal Kozlovski, Inbal Maidan, Eran Gazit, Amgad Droby, Avner Thaler

Brain Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.
Saar Anis, Caroline Weill, Penina Ponger, Maria Nassar, Johnathan Reiner, Avner Thaler

Parkinsonism Relat Disord· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD).
Nurit Omer, Amgad Droby, Rawan Silbak, Noa Trablus, Aya Bar David, Avner Thaler

J Neurol Neurosurg Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of polygenic risk score on PD risk and phenotype in G2019S and carriers.
Orly Goldstein, Shachar Shani, Mali Gana-Weisz, Nadav Elkoshi, Fergal Casey, Avner Thaler

J Parkinsons Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.
Amgad Droby, Avital Yoffe-Vasiliev, Daniel Atias, Kyle B Fraser, Omar S Mabrouk, Avner Thaler

NPJ Parkinsons Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset.
Shachar Shani, Mali Gana-Weisz, Anat Bar-Shira, Avner Thaler, Tanya Gurevich

J Parkinsons Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutations.
Avner Thaler, Saar Anis, Penina Ponger, Tsviya Fay-Karmon, Vered Livneh

Parkinsonism Relat Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson's disease.
Ofir Sade, Daphna Fischel, Noa Barak-Broner, Shir Halevi, Irit Gottfried, Avner Thaler

Front Mol Neurosci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TMS-evoked potentials unveil occipital network involvement in patients diagnosed with Parkinson's disease within 5 years of inclusion.
Noa Zifman, Ofri Levy-Lamdan, Tal Hiller, Avner Thaler, Iftach Dolev

NPJ Parkinsons Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers.
Tamara Schejter-Margalit, Noam Ben Binyamin, Avner Thaler, Inbal Maidan, Jesse M Cedarbaum

Eur J Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease.
Avner Thaler, Vered Livne, Einat Rubinstein, Nurit Omer, Achinoam Faust-Socher

Parkinsonism Relat Disord· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amantadine Responsive Methcathinone (Ephedrone) Induced Parkinsonism.
Avner Thaler, Tanya Gurevich

Mov Disord Clin Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Mobility Measures: A Window into Real-World Severity and Progression of Parkinson's Disease.
Anat Mirelman, Jana Volkov, Amit Salomon, Eran Gazit, Alice Nieuwboer, Avner Thaler

Mov Disord· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Locus in Parkinson's Disease Patients of Ashkenazi Origin: A Stratified Analysis.
Shachar Shani, Mali Gana-Weisz, Anat Bar-Shira, Avner Thaler, Tanya Gurevich

Genes (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overnight Distribution of REM Sleep Features in People with Parkinson's Disease (PD) and Non-PD Controls.
Andrew Dagay, Shani Oz, Shlomit Katzav, Danielle Wasserman, Riva Tauman, Avner Thaler

J Parkinsons Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
Eva-Juliane Vollstedt, Harutyun Madoev, Anna Aasly, Azlina Ahmad-Annuar, Bashayer Al-Mubarak, Avner Thaler

PLoS One· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Genetic Testing and Counseling Practices for Parkinson's Disease.
Rachel Saunders-Pullman, Deborah Raymond, Roberto A Ortega, Ali Shalash, Emilia Gatto, Avner Thaler

Mov Disord· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Testing in Parkinson's Disease.
Gian Pal, Lola Cook, Jeanine Schulze, Jennifer Verbrugge, Roy N Alcalay, Avner Thaler

Mov Disord· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Markers in Genetic Forms of Parkinson's Disease.
Amgad Droby, Avner Thaler, Anat Mirelman

Brain Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective on the current state of the LRRK2 field.
Jean-Marc Taymans, Matt Fell, Tim Greenamyre, Warren D Hirst, Adamantios Mamais, Avner Thaler

NPJ Parkinsons Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants in PSMB9 and FGR differentially affect Parkinson's disease risk in GBA and LRRK2 mutation carriers.
Shachar Shani, Orly Goldstein, Mali Gana-Weisz, Anat Bar-Shira, Avner Thaler

Parkinsonism Relat Disord· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel variants in genes related to vesicle-mediated-transport modify Parkinson's disease risk.
Orly Goldstein, Mali Gana-Weisz, Sandro Banfi, Vincenzo Nigro, Anat Bar-Shira, Avner Thaler

Mol Genet Metab· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol.
Noa Bregman, Tamara Shiner, Gitit Kavé, Roy Alcalay, Mali Gana-Weisz, Avner Thaler

BMC Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide case-only analysis of gene-gene interactions with known Parkinson's disease risk variants reveals link between LRRK2 and SYT10.
Milda Aleknonytė-Resch, Joanne Trinh, Hampton Leonard, Sylvie Delcambre, Elsa Leitão, Avner Thaler

NPJ Parkinsons Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis